Our team has led and executed milestone projects across ischemic heart disease, heart failure, arrhythmias, valve disorders, congenital heart disease, and peripheral artery disease.
Our cardiovascular clinical capabilities include:
Protocol design that integrates real-time ECG monitoring and biomarkers
Agile, customized strategies that span early to post-marketing phases
Deep site engagement and patient enrollment expertise in high-risk populations
Full-service regulatory and GCP inspection-readiness support
Notable successes include the completion of a large Phase IV trial evaluating the safety of ticagrelor in 2,000+ ACS patients across 104 centers, meeting stringent NMPA standards. We also supported the registration of a domestic abdominal aortic covered stent system—offering new treatment choices and lowering patient burden in China.
GCP ClinPlus is proud to be a trusted partner to both international and domestic cardiovascular innovators, bridging clinical science and regulatory pathways to bring life-saving therapies to patients faster.